To assess the prognostic significance of Cideb expression, we divided the ccRCC patients into two groups: those with high Cideb expression (>20 %), and those with low Cideb expression (absence or <20 % positive cells). This evidence concerns the gene CIDEB and nonpapillary renal cell carcinoma.